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Abstract
Background: Surgical removal of primary tumors can promote the incidence of tumor metastasis. However,
molecular mechanisms underlying this process remain unclear.
Methods: We inoculated tumor cells expressing luciferase gene into subiliac lymph node (SiLN) of the MXH10/
Mo-lpr/lpr mice. The tumor-bearing SiLNs were surgically removed at a certain period of time after inoculation.
Results: In vivo bioluminescence imaging system and histological staining revealed metastasis in lung, proper
axillary lymph node (PALN) and liver. The lung metastasis rate in SiLN removal groups was significantly higher than
in the control group using Fisher exact test. Mann-Whitney U-test indicated that the luciferase-positive tumor cells
in the lung and liver were significantly higher than in the control groups. The lung samples in SiLN removal groups
had strong expression of lysine oxidase (LOX). Moreover, the number of CD11b+ cells in the lung and liver in the
SiLN removal groups was significantly increased, which was positively correlated with LOX expression level. In
addition, the condition of LOX and CD11b in liver was similar to lung. In the SiLN surgical removal groups, the
matrix metalloproteinase (MMP)-2 and VEGFA expression in the lung tissues was significantly higher than in the
control groups; the collagen fibers per area around the pulmonary vessels was quite significantly lower and
negatively correlated with the expression of MMP-2 by Spearman’s analysis. Our data indicated that the reticular
fibers were deposited and disordered in the tumor tissues of the lungs in the removal groups, and the reticular
fibers per area was higher than in the control groups. The tumor cells in the PALN of control groups were
significantly higher than in the SiLN removal groups, and CD169+ and CD11c+ cells were also higher than in the
SiLN removal groups.
Conclusions: Altogether, surgical removal of the tumor-bearing lymph node promoted tumor metastasis through
changing the niche in lung and liver. Treatment targeting the metastatic niche might be an effective strategy to
prevent tumor metastasis, thereby possibly increasing the survival and reducing the incidence of metastasis in
cancer patients.
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Background
Surgical removal, radiotherapy, or angiogenesis inhibi-
tor treatments usually have physiological impacts or
induce local trauma on the body, thereby leaving a
chance for the survival of tumor cells [1–3]. As a re-
sult, the harm from the tumor has been transformed
from the harm caused by the primary tumor to the
damage derived from metastases [4] or the harm
caused by the treatment itself, but there are no effect-
ive prevention and treatment measures in clinical
practice. The current detailed mechanism of tumor
metastasis is not very thorough, and the therapeutic
regimens for metastatic tumors are very rare and in-
efficient. Therefore, the clarification of the mechanism
of tumor metastasis is important for the prevention
and treatment of metastatic cancer.
The “seed and soil” hypothesis has long been used
to explain tumor metastasis, i.e., cancer cells are con-
sidered to be seeds that spread to certain places in
the body and soil refers to cytokine formation and
the recruitment of cells to cultivate the proper tumor
microenvironment; tumor cells eventually begin to
plant and grow at the pre-metastatic site at the ap-
propriate time [5]. Kaplan and his colleagues first
proposed the concept of the pre-metastatic niche in
2005 [6]. The primary tumor cells carefully plan the
formation of the pre-metastatic niche by secreting a
variety of cytokines and growth factors that promote
the movement of bone marrow-derived cells (BMDCs)
to gather in pre-metastatic sites. Research of the
pre-metastatic niche has become more and more
in-depth and it has been taken into consideration that
primary tumors affect and change the microenviron-
ment of the secondary organs by promoting the
formation of the pre-metastatic niche before the dis-
semination of tumor cells [7, 8]. Metastasis is closely
associated with the formation of the pre-metastatic
niche [7, 8]. A study by Kaplan et al. showed that
vascular endothelial growth factor (VEGF) generated
by primary tumor promotes the production of fibro-
nectin and the secretion of MMP-9 to establish the
pre-metastatic niche for invasive tumor cells [2].
Other studies have shown that primary tumors form
tumor-derived secreted factors (TDSFs) to promote
the recruitment of BMDCs, which react with the
extracellular matrix of the target organ at the
pre-metastatic site to change the microenvironment
of the target organs and to promote tumor cell
colonization and growth, thereby greatly enhancing
the rate of tumor metastasis [6–8].
Therefore, it is necessary to further understand exist-
ing anti-cancer therapeutic techniques and tumor metas-
tasis patterns to improve therapeutic regimens in an
alternative manner, with the intention of reversing the
impact of the metastatic niche and enhancing thera-
peutic efficacies and improving cancer prognoses.
Although the dissection of the primary tumor is bene-
ficial, it may disturb metastatic homeostasis [9], resulting
in the activation and rapid growth of latent tumors in
distant organ, which has been suggested in several can-
cer types including breast, lung and head and neck can-
cers [10–12]. Due to being inspired by above papers and
a model that has been proposed to explain the recur-
rence of breast cancer in a patient after surgical resec-
tion of the tumor [13], we wonder if removal of
tumor-bearing lymph node (LN) may accelerate the oc-
currence of cancer metastasis. Similarly, our research
showed that iatrogenic induction of distant cancer me-
tastasis in the lung is activated after resection of a
tumor-positive lymph node in a lymph node metastasis
mouse model [14]. However, the concrete and detailed
mechanisms are not clear.
In this study, we inoculated tumor cells directly
into the subiliac lymph node (SiLN) to construct a
lymph node metastasis mouse model and simulate
tumor metastasis to local lymph node. This in vivo
metastasis model is stable, highly efficient, and repro-
ducible [14]. Unlike the research background of previ-
ous studies in metastasis, we did not use any in vivo
models with spontaneous metastasis, but we used an
in vivo model with accelerated metastasis after surgi-
cal removal of tumors.
This study examined the colonization and growth of
cancer cells in the proper axillary lymph node (PALN),
lung and liver tissues after the surgical removal of
tumor-bearing SiLN. We also monitored the expression
level of tumor cell-secreted LOX, MMP-2 and VEGFA,
and the bone marrow-derived CD11b+ cell number in
the distant organs in the in vivo model. In addition, we
analyzed the expression of collagen fibers and reticular
fibers in the lung of different experimental groups to
evaluate if the changes of fibrous structures affect the
colonization and clonal growth of metastatic tumor cells
at the metastatic sites.
This study was based on the molecular changes associ-
ated with the formation of the metastatic niche after the
surgical removal of tumor-bearing lymph node; we stud-
ied the mechanism of surgery-induced tumor metastasis
and hope to provide new ideas and a theoretical basis to
prevent and treat tumor metastasis. Further understand-
ing of metastatic niche formation will help with the dis-
covery of new therapeutics and lead to the radical
treatment of tumor metastasis.
Methods
Experiments were carried out in accordance with pub-
lished guidelines and were approved by the Institutional
Animal Care and Use Committee of Tohoku University.
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Mice
MXH10/Mo-lpr/lpr (MXH10/Mo/lpr) mice (13–15 weeks
of age, 37 ± 2 g) were bred under pathogen-free conditions
in the Animal Research Institute, Tohoku University [15].
The mice in the FM3A group are female, while the mice
in the KM group are male.
Cell lines
Two types of cells lines were used: malignant fibrous
histiocytoma-like KM-Luc/GFP cells and C3H/He
mouse mammary carcinoma cells (FM3A-Luc), which
were stably expressing the luciferase gene [16].
Lymph node metastasis mouse model
KM-Luc/GFP (final concentration: 3.3 × 105 cells/mL) or
FM3A-luc (final concentration: 3.3× 106cells/mL) cells
were suspended in a mixture of 20 mL phosphate buff-
ered saline (PBS) and 40 mL of 400 mg/mL Matrigel
(Collaborative Biomedical Products). The concrete pro-
cedures of injecting tumor cells into the SiLN and resec-
tion of the SiLN see literature 14. 3 and 6 days after
inoculation of KM-Luc/GFP cells or 3 and 7 days after
inoculation of FM3A-Luc cells into SiLN, the
tumor-bearing SiLN was surgically removed.
In vivo bioluminescence imaging system
Tumor development in the SiLN and metastasis to the
PALN, lungs and livers were detected using an in vivo
bioluminescence imaging system (IVIS; Xenogen, USA)
[17]. This procedure was carried out separately at 6 h,
3 days, 6 days and 9 days after inoculation of KM-Luc/
GFP cells into the SiLN (KM group), and at 3 days,
7 days, 14 days and 21 days after inoculation of
FM3A-Luc cells into the SiLN (FM3A group). Moreover,
the IVIS was done immediately after and before surgical
removal of the SiLN. The luciferase activities of the re-
moved lungs, PALN and liver were measured ex vivo by
IVIS on day 9 in KM group and day 21 in FM3A group,
respectively.
Tissue preparation
Mice were anesthetized using an inhaled mixture of 2%
isoflurane and oxygen. All the harvested samples includ-
ing lung, PALN and liver were fixed overnight in 18.5%
formaldehyde, dehydrated and embedded in paraffin.
Half of PALNs were embedded in OCT.
Immunohistochemistry
Paraffin samples were sectioned at 3 μm thickness.
0.01 M citrate buffer solution (pH 6.0) was used for
retrieval treatment at 120 °C for 5 min. Dako Target
Retrieval Solution (S1699, Dako) was used during F4/80
immunohistochemical staining. After washing in
phosphate-buffered saline (PBS), the tissue sections were
incubated with normal animal serum (1:10 in PBS) from
which the second antibodies were obtained for 30 min at
37 °C. A blocking kit (414,321, Histofine Company,
Japan) was used according the instruction book during
MMP-2 staining. Afterwards, the tissue sections were
washed and incubated with the following primary anti-
bodies at 4 °C overnight: Rabbit polyclonal antibody to
Firefly luciferase (ab21176, 1:500, abcam), Rabbit
polyclonal antibody to LOX (ab31238, 1:100, abcam), Rat
anti-mouse CD11b Monoclonal Antibody (MCA711G,
1:500, AbD serotec), mouse monoclonal to MMP-2
(ab86607, 1:200, abcam), Rabbit polyclonal to VEGFA
(ab183100, 1:50, abcam), rat monoclonal antibody to F4/80
(ab6640, 1:100, abcam), Armenian hamster monoclonal to
CD11c (ab33483, 1:500, abcam). After washing in PBS, the
sections were treated with 0.3% hydrogen peroxide in
methanol for 20 min at room temperature (RT) to
eliminate the endogenous peroxidase activity. The cor-
responding peroxidase-conjugated second antibodies (imme-
diately used, Histofine company, Japan) were applied for
30 min at RT. For CD11c staining, biotin-labelled secondary
antibody (ab5744, 1:500, abcam) and peroxidase-conjugated
streptavidin were applied for 30 min at 37 °C. Positive reac-
tions were developed with diaminobenzidine (DAB). The
negative control was performed except that the primary anti-
body was replaced by PBS. Frozen sections were used for
CD169 monoclonal staining. Rat anti mouse CD169
(ab53443, 1:200, abcam) was applied at RT for 2 h. The rest
procedures are identical to those applied on paraffin
sections.
Special histological staining
Elastic-Masson (EM) staining combines elastic and tri-
chrome staining techniques for demonstration and clear
definition of elastic fibers of all sizes, connective tissue
and nuclei in a single tissue section. Paraffin-embedded
lung tissues were carried out with silver impregnation
staining to display reticular fibers and to observe the dis-
tribution of reticular fibers in lungs [18].
Computer-aided morphological analysis
Image Pro Plus 6.0 (Media Cybernetics Inc., Rockville,
MD, USA) was used to calculate the intensity and extent
of staining for the detected molecules, the ratio of the
collagen fibers around blood vessels by EM staining and
the ratio of the reticular fibers by silver impregnation
staining area to the total area of the image in the lung
tissues. Three microscopic fields (original magnification
200×) were randomly selected. The integral optical dens-
ity (IOD) of luciferase, LOX, CD11b, MMP-2, VEGFA,
CD11c, F4/80 and CD169 positive staining was calcu-
lated and was considered as the expression level of cor-
responding molecules. The per-area density of EM and
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silver positive staining was calculated to reflect the per-
centage of the collagen and reticular fibers.
Statistical analysis
Statistical analyses were performed with SPSS software
version 18.0 (SPSS Inc., Chicago, IL). Statistical differences
were analyzed using the Mann-Whitney U-test for 2
independent groups and Fisher exact test was used to
compare the incidence of metastasis (%) between groups.
Spearman’s rank correlation coefficient test was used to
examine the correlations among the expressions of lucifer-
ase, collagen fiber, MMP-2, Lox and CD11b. Continuous
data were presented as the median (IQR). Statistical differ-
ences were considered significant when the P < 0.05.
Fig. 1 In vivo and ex vivo detection of metastases using in vivo bioluminescence imaging system. a KM-Luc/GFP cells were injected into the SiLN
(n = 22) (KM group). The SiLN was removed 3 days (G-D3 group, n = 9), or 6 days (G-D6 group, n = 8) after tumor cell inoculation. SiLNs that were
injected with KM-Luc/GFP cells but not removed were used as control (G-C group, n = 5). b FM3A-Luc cells were injected into the SiLN (n = 15)
(FM3A group). The SiLN was removed 3 days (G-D3 group, n = 4), or 7 days (G-D7 group, n = 6) after tumor cell inoculation. SiLNs that were
injected with FM3A-Luc cells but not removed were used as control (G-C group, n = 5). c-d The lung, PALN and liver metastasis rate in the
control and SiLN removal groups. e-f The ex vivo luciferase activity of the lung in the control and SiLN removal group
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Results
In vivo and ex vivo detection of metastases using IVIS
We established the mouse model via surgical removal of
the tumor-bearing lymph node promoting tumor metas-
tasis in distant organs. The SiLNs bearing tumor cells
were surgically removed at 3 and 6 days (KM group) or
7 days (FM3A group) after inoculation, respectively. The
mice were observed by the IVIS (Fig. 1a, b). Lung metas-
tasis first appeared 9 days after inoculation in the KM
control group (G-C) without the surgical removal of the
tumor-bearing SiLN and the lung metastasis rate was
20%. At 9 days after inoculation, the lung metastasis rate
in the SiLN removal group (G-D3 and G-D6) was
82.35%, which was significantly higher than in the con-
trol group (P = 0.021) (Fig. 1c). Similarly, in FM3A
group, Fig. 1d shows the lung metastasis rate was 20% in
control group. Lung metastasis first appeared 21 days
after inoculation. At 21 days after inoculation, the lung
metastasis rate in the SiLN removal group was 100%,
which was significantly higher than in the control group
(P = 0.004).
The PALN metastasis rate was 20 and 23.53% in the
control and SiLN removal groups for KM group, respect-
ively, and there was no statistical significance. The PALN
metastasis rate was 20% in both control and SiLN removal
groups for FM3A group. The liver metastasis rate was
5.9% in the SiLN removal KM group, and no liver metas-
tasis was found in the KM and FM3A control groups
(Fig. 1c, d). The luciferase activity of the lung ex vivo in
the SiLN removal group was significantly higher than in
the KM and FM3A control group (Fig. 1e, f ).
IHC staining analysis of luciferase in PALN, lung and liver
To confirm the IVIS results, we stained sections of
PALN, lung and liver with and without SiLN removal in
KM and FM3A group for tumor cells marker luciferase.
Fig. 2 The expression of luciferase in PALN, Lung and liver. The Immunohistochemical (IHC) staining of luciferase in PLAN (left panel), lung
(middle panel) and liver (right panel) of the KM (a) and FM3A (b) groups. Bar: 100 μm
Table 1 Expression level of luciferase in PLAN, Lung and liver
PALN Lung Liver
IOD Median(IQR) P value IOD Median(IQR) P value IOD Median(IQR) P value
KM group G-C 489.79(161.99) 0.001a 107.97(33.41) < 0.001a 16.85(8.85) 0.254a
G-D3 151.54(68.71) 0.945b 309.73(48.36) 0.005b 20.29(9.95) 0.106b
G-D6 171.47(13.86) 0.002c 416.96(99.09) < 0.001c 30.19(7.73) 0.003c
FM3A group G-C 388.61(52.09) 0.016a 183.76(33.56) < 0.001a 12.14(1.39) 0.421a
G-D3 219.94(29.07) 0.009d 407.27(31.04) 0.127d 13.97(3.40) 0.691d
G-D7 127.55(34.01) 0.004c 432.17(13.64) 0.002c 15.26(0.91) 0.310c
P < 0.05 was considered significant
IOD integral optical density
acompared with G-D3
bcompared with G-D6
ccompared with G-C
dcompared with G-D7
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In the KM and FM control groups, tumor nests
were observed in some PALNs. In addition, scattered
luciferase-positive tumor cells were seen in the blood
vessels and between the alveolar epithelial cells in
lung. At the same time, luciferase-positive tumor cells
were seldom found in liver (Fig. 2a, b).
In both the KM and FM3A groups with the surgical
removal of tumor-bearing SiLN, the IOD value of the
luciferase-positive tumor cells in the PALNs were sig-
nificantly lower than in the control groups (Table 1).
Tumor nests of different sizes were observed around
the terminal bronchi and in the distal alveoli in lung.
Moreover, small satellite-like metastatic foci were ob-
served in some livers and scattered luciferase-positive
tumor cells were found within the liver blood sinus
(Fig. 2a, b). Compared with the control group, the
tumor burden in lung was significantly increased in
all SiLN groups and there was statistical difference
only between G-D6 and G-C of KM groups in liver
(Table 1).
The lung metastatic niche
To investigate the influence of surgical removal of SiLN
on metastatic site and explore the pathophysiology of
the local tissue microenvironment in lung, we performed
the immunohistochemical staining for LOX, CD11b,
MMP-2, and VEGFA. LOX is critical for pre-metastatic
niche formation and is essential for recruitment of
BMDCs [19, 20]. LOX showed strong staining in both
KM and FM3A SiLN removal groups.CD11b+ BMDCs
have a variety of functions which may enhance
metastatic tumor growth. We found CD11b+ clusters
abundantly located in lung in KM and FM3A SiLN re-
moval groups, while clusters of CD11b+ cells were sel-
dom observed in both control groups. The expression of
MMP-2 and VEGFA indicated a role in matrix changes
and angiogenesis. The high expression of MMP-2 and
VEGFA were also detected in our SiLN removal model
(Fig. 3a, b).
Statistical analysis showed the expression of LOX,
CD11b, MMP-2 and VEGFA in all of the KM and FM3A
Fig. 3 The changes of metastatic niche in lung samples. The expression of LOX, CD11b, MMP-2 and VEGFA were determined using IHC staining
in the KM (a) and FM3A (b) groups. Bar: 50 μm
Table 2 The expression level of LOX, CD11b, MMP-2 and VEGFA in lung
KM group FM3A group
Control SiLN removal P value Control SiLN removal P value
IOD Median (IQR) Lox 159.88(74.58) 432.19(133.55) < 0.001 81.30(41.28) 527.83(72.49) 0.002
CD11b 419.05(162.82) 1457.15(228.39) < 0.001 480.03(58.28) 846.84(68.05) < 0.001
MMP-2 395.32(174.29) 1369.99(187.05) < 0.001 327.07(63.52) 2098.03(165.68) < 0.001
VEGFA 107.46(24.58) 796.19(76.57) 0.002 82.35(15.72) 1192.30(279.41) < 0.001
P < 0.05 was considered significant
IOD integral optical density
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SiLN removal groups was significantly higher than in the
corresponding control group (Table 2). We also analyzed
the correlation among the LOX, CD11b, MMP-2 and lu-
ciferase by Spearman’s correlation analysis. In both the
KM and FM3A SiLN removal groups, the expression
level of LOX showed a positive correlation with the
expression level of luciferase (r = 0.767, P = 0.001; r = 0.745,
P = 0.013;Table 3) and CD11b (r= 0.733, P= 0.025; r= 0.721,
P= 0.019; Table 3), respectively. The expression level of
CD11b showed a positive correlation with the expression
level of MMP-2 (r= 0.786, P= 0.036; r= 0.709, P= 0.022;
Table 3).
Matrix changes promotes metastatic tumor growth in the
lung
MMP-2 is known for cleaving extracellular matrix. Using
Elastic Masson staining and silver impregnation method,
we observed the changes of collagen fibers and reticular fi-
bers. With EM staining, blue-green collagen fibers were
determined to be evenly located around the bronchi and
blood vessels in the control group. Collagen fibers located
around the bronchi and blood vessels in the SiLN removal
groups were sparse and almost not found. Positive
silver-stained reticular fibers were black. The reticular fi-
bers in the lungs in both control groups were slender,
loosely arranged, and interwoven into networks.
Compared with the corresponding control group, the re-
ticular fibers in the lungs in all of the SiLN removal
groups were obviously increased and fractured (Fig. 4a, b).
The difference of collagen fiber per area was significant
between the control group and the SiLN removal groups
in both KM and FM3A groups. The difference of reticular
fiber per area was significant between the control group
and the SiLN removal groups in both KM and FM3A
groups (Table 4). The expression level of MMP-2
showed a negative correlation with the collagen fibers per
area (r = − 0.847, P = 0.016;r = − 0.748,P = 0.013;Table 5).
Moreover, the per area of collagen fibers showed a negative
correlation with the expression level of luciferase-positive
tumor cells in both the KM and FM3A SiLN removal
groups (r = − 0.865, P = 0.012;r = − 0.681, P = 0.030;Table 5),
which mean that the quantity of collagen fibers around the
bronchi and blood vessels were negatively correlated with
the tumor metastatic foci burden.
Surgical removal of SiLN enhanced expression of LOX and
CD11b in liver
We also investigated the expression of LOX and CD11b
in the liver tissues (Fig. 5a, b). The situation was similar
to the data obtained in the lungs. The expression levels
of LOX and CD11b in the liver in all of the KM and
FM3A SiLN removal groups were significantly higher
than in the corresponding control group (P < 0.001,
Table 6).
Anti-tumor response in tumor-draining PALN
To observe morphological and histological changes in
PALN, we performed HE staining. Tumor cells flowed
into the subcapsular sinus of the PALN 3 and 7 days
after inoculation in the KM and FM control groups,
Table 3 Correlation among the expression level of LOX,
luciferase, CD11b and MMP-2 in lung of KM and FM3A SiLN
removal groups
KM group FM3A group
LOX Luciferase P = 0.001, r = 0.767 P = 0.013, r = 0.745
LOX CD11b P = 0.025, r = 0.733 P = 0.019, r = 0.721
CD11b MMP-2 P = 0.036, r = 0.786 P = 0.022, r = 0.709
P < 0.05 was considered significant; r: Spearman correlation coefficient
Fig. 4 Location and expression of collagen fibers and reticular fibers. Location and expression of collagen fibers (left panel) and reticular fibers
(right panel) were analyzed by Elastic-Masson (EM) staining and silver impregnation method in the KM (a) and FM3A (b) groups. Bar: 100 μm
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respectively. As time went by, tumor cells were found in
lymphatic sinuses and tumor nests formed (Fig. 6a, b).
Lymph nodes play a key role in orchestrating im-
mune response against tumors. An important event is
the presentation of tumor antigens within the
tumor-deriving lymph node. Macrophages and den-
dritic cells are professional antigen-presentation cells.
Macrophages can be identified according to the ex-
pressions of F4/80 and CD169. We did not observe
significant changes in the numbers of F4/80+ mature
macrophages between KM and FM3A control groups
and SiLN removal groups, respectively. However, we
found that the numbers of CD11C+ and CD169+ cells
in the PALNs in both the KM and FM SiLN control
groups were significantly higher than in the corre-
sponding SiLN removal groups (P < 0.001, Fig. 6c, d;
Table 7).
Discussion
An operation to treat cancer includes resection of the pri-
mary lesion, lymphadenectomy, reconstruction, and so on.
To date, surgery has been considered to be the primary
therapeutic regimen for most malignancies, even though
sometimes the effect of surgery is not ideal, since the surgi-
cal process could increase the risk of metastases of residual
cancer cells to other organs [1, 4, 21]. Experimental data
suggest that increased surgical stress augments cancer me-
tastasis via surgical stress-induced expression of proteinases
in the target organ of metastasis [22]. The effect of surgery
on metastasis may be attributed to a number of factors, in-
cluding immunosuppression after surgical stress, action of
cytokines or changes of tumor microenvironment [23]. To
explain the presence of postoperative tumor metastasis, it is
necessary to find the appropriate in vivo model, thereby
gaining an in-depth understanding of the mechanism of
tumor removal-induced metastasis in order to develop ef-
fective treatment options and to improve metastatic cancer
prevention and treatment.
Our IVIS results showed that the surgical removal
of tumor-bearing SiLN promoted the incidence of
lung metastasis (Fig. 1). Further, immunohistochemis-
try showed that luciferase-positive tumor cells were
sparsely spread in the control lung tissues and was
significantly lower than in the SiLN removal group.
Although there was no significant difference in the
rate of PALN metastasis between the control and
tumor-bearing SiLN removal group, the number of
luciferase-positive tumor cells in PALN in the surgical
SiLN removal group was significantly less than the
control group (Fig. 2, Table 1).
The pre-metastatic niche is defined as microenviron-
ment with a series of molecular and cellular changes,
which forms a supportive and receptive pre-metastatic
site and the fertile “soil” to prepare for the colonization
of “seed”, that is metastatic tumor cells, thereby facilitat-
ing tumor cell adhesion and growth in the distant organs
and promoting tumor metastasis [8]. Studies have shown
that local and high-precision radiotherapy does not in-
duce direct injury, but it directly kills or stimulates the
tissue cells compared with surgery, which also acceler-
ates the incidence of tumor metastasis during
anti-cancer therapy [2, 24]. Previous studies have shown
that local radiotherapy causes a stronger expression of
angiogenic factors than anti-angiogenic factors and
disturbs the configuration imbalance of VEGFs in the
vascular bed of the metastatic site, which then results in
outbreak growth of dormant metastatic tumors [24, 25].
Adjuvant applications of the exogenous VEFGR inhibitor
cediranib after radiotherapy restored tumor inhibition,
and studies have shown that using angiogenesis inhibi-
tors to target the VEGF pathway or knocking out the
VEGF gene in mouse models with pancreatic cancer or
glioblastoma has anti-cancer therapeutic effects by
reducing the tumor volume and prolonging survival, but
the two actions change tumor phenotypes and enhance
tumor invasion and metastasis [26–28]. The discontinu-
ation of VEGF inhibitors still enhances the tumor
invasion, suggesting that this treatment increases the persist-
ence of tumor invasion. This implies that not only does the
treatment-induced trauma lead to tumor-promoting
responses, but the disappearance of the tumor itself also
promotes tumor metastasis during anti-cancer therapy. For
the tumor treatment targeting a single angle, tumors can
derive responses of increased invasiveness and extended
metastasis. Therefore, a comprehensive consideration of all
Table 4 Per area of collagen fibers and reticular fiber in lung
Collagen fibers Reticular fibers
per area (%) P value per area (%) P value
KM group G-C 0.0148(0.0045) 0.008a 0.0118(0.0018) 0.001a
G-D3 0.005(0.001) 0.464b 0.0209(0.0013) 0.008b
G-D6 0.0043(0.0021) 0.002c 0.026(0.005) 0.008c
FM3A group G-C 0.038(0.009) 0.001a 0.025(0.004) 0.001a
G-D3 0.024(0.007) 0.006d 0.044(0.008) 0.019d
G-D7 0.007(0.003) 0.003c 0.054(0.012) 0.002c
P < 0.05 was considered significant; Data are expressed as the median (IQR)
acompared with G-D3
bcompared with G-D6
ccompared with G-C
dcompared with G-D7
Table 5 Correlation among per area of collagen fibers, the
expression level of luciferase and MMP-2 in lung of KM and
FM3A SiLN removal groups
KM group FM3A group
collagen fibers MMP-2 P = 0.016, r = −0.847 P = 0.013, r = − 0.748
collagen fibers Luciferase P = 0.012, r = − 0.865 P = 0.030, r = − 0.681
P < 0.05 was considered significant; r: Spearman correlation coefficient
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characteristics of the tumor microenvironment may accom-
plish a radical anti-cancer treatment.
Studies have shown that LOX secreted from hypoxic
primary tumor cells accumulates in the pre-metastatic
sites; LOX is an indispensable factor for recruiting bone
marrow-derived CD11b+ cells (i.e., immature myeloid
progenitor cells) to metastatic sites [19, 20]. LOX ex-
pression in SiLN removal groups was significantly higher
than in the control group and was positively correlated
with luciferase expression. These findings are consistent
with the results of previous studies [19, 20], suggesting
that high LOX expression in the metastatic sites was
closely associated with the colonization and metastasis
of tumor cells. Moreover, the number of CD11b+ cells in
the lung and liver of the mice in the SiLN removal
groups was significantly increased, which was positively
correlated with LOX expressions (Fig. 3, Tables 2, 3).
Since the activation of MMP increased the invasion of
BMDCs [19, 29], we detected MMP-2 expression in the
lung tissues of the surgical SiLN removal groups, which
was interestingly higher than that in the control groups
and it was positively correlated with CD11b expression
(Fig. 3, Tables 2, 3).
Our results showed that the degradation of the collagen
fibers around the pulmonary vessels in the lungs of mice
with the surgical removal of tumor-bearing SiLN was
quite significant and the quantity of collagen fibers was
negatively correlated with the expression of MMP-2, lead-
ing to a decrease in barrier function, thereby providing a
channel for the tumor cells to invade blood vessels and
establishing helpful conditions for tumor cell metastasis.
The fracture of reticular fibers in the SiLN removal groups
facilitated tumor cell invasion, thereby accelerating lung
metastasis (Fig. 4, Table 5).
The above results suggested that high LOX and
MMP-2 expressions and a great number of CD11b+ cell
facilitate the formation of the metastatic niche and the
colonization, growth, and invasion of tumor cells in the
lung. The accumulation of LOX at the metastatic site
promoted CD11b+ BMDC adhesion, MMP-2 production,
and degradation of intra-pulmonary vascular collagen.
Moreover, the morphological changes of the extracellular
matrix scaffold remodeled the local microenvironment
and enhanced tumor cell invasion. Previous studies have
shown that BMDC induced interstitial epithelial trans-
formation of the disseminated tumor cells [30], secreted
chemokines to enhance metastasis and nesting of tumor
cells [31], and lowered in vivo immune surveillance by im-
munosuppression [7, 8, 32]. The current study also
showed that VEGFA expression in the surgical removal
groups was significantly higher than in the control group,
and it is known that the secretion of VEGF and other an-
giogenic factors promote vascular angiogenesis, thereby
possibly playing a synergistic role in promoting tumor
metastasis.
The current study also identified LOX, CD11b, and lu-
ciferase expression in the liver and showed similar expres-
sion patterns of LOX and CD11b in the lung (Fig. 5).
Interestingly, although the ex vivo IVIS results showed
that the liver metastasis was only 5.9% in KM SiLN re-
moval group, immunohistochemical staining showed that
luciferase-positive tumor cells were scattered in liver
Fig. 5 The changes of metastatic niche in liver samples. The expression of LOX and CD11b were observed using IHC staining in the KM (a) and
FM3A (b) groups. Bar: 20 μm
Table 6 The expression levels of LOX and CD11b in liver
KM group FM3A group
Control SiLN removal P value Control SiLN removal P value
IOD Median(IQR) Lox 146.78(17.19) 318.88(53.53) < 0.001 102.35(30.71) 210.76(43.29) < 0.001
CD11b 376.03(50.23) 755.90(21.10) < 0.001 319.62(33.35) 588.03(34.53) < 0.001
IOD: integral optical density; P < 0.05 was considered significant
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sinusoids in all of the SiLN removal groups (Fig. 2), which
might be associated with tumor cell types and organotro-
pic targeting [33], unfavorable niche formation, or the
short observation time in this study. Further studies will
be necessary to address the above concerns.
Lymph nodes are the well-known routes for lymph-
atic metastasis and the primary place for anti-tumor
immune responses. The current study observed the
influx of tumor cells into the lymphoid sinus of
PALN in the control group, which resulted in tumor
nest formation, the retention of tumor cells, and the
reduction of tumor cell metastasis to distant organs over
time (Fig. 6). A study by Asano et al. [34] showed that
subcutaneously injected tumor cells can be transported to
lymph nodes (LNs) through the lymphatic flow and were
phagocytosed by CD169+ macrophages in the LN subcap-
sular sinus, which then directly cross-present the dead
cell-associated antigens to CD8+T cells. The current study
found a large luciferase-positive cell influx into the sub-
capsular sinus in the PALN of the control group. In
addition, the number of CD169+ and CD11c+ cells in the
control group was significantly higher than in the SiLN re-
moval groups (Fig. 6, Table 7), suggesting the production
of anti-tumor immune responses, which, to a certain ex-
tent, reduced the chance of tumor cell metastasis to the
distant organs, such as the lung and liver.
Fig. 6 Histological changes in tumor-draining PALN. a-b HE staining of PALN in mice in KM (a) and FM3A (b) control groups. As time went by,
tumor cells were found in lymphatic sinuses and tumor nests formed. c-d The expression of F4/80, CD169 and CD11c in PALN were analyzed by
IHC staining. Bar: (a-c) 100 μm, (d) 50 μm
Table 7 The expression levels of F4/80, CD169 and CD11c in tumor-draining PALN
KM group FM3A group
Control SiLN removal P value Control SiLN removal P value
IOD Median (IQR) F4/80 8431.42(2520.87) 7726.41(824.07) 0.423 5172.4(552.41) 5028.82(1072.5) 0.356
CD169 3213.51(240.77) 1026.38(281.09) < 0.001 1394.34(489.14) 622.89(254.42) < 0.001
CD11c 368.04(65.7) 179.87(80.47) < 0.001 486.99(168.8) 173.73(74.75) < 0.001
P < 0.05 was considered significant
IOD integral optical density
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There is growing data to support that noncoding
RNAs (ncRNAs) play a significant role in tumor metas-
tasis [35, 36]. A diversity of ncRNAs was demonstrated
to promote proliferation and metastasis of tumor cells
[37–39]. We preformed additional microarray detection
and indicated expression differences in both miRNAs
and lncRNAs (data not shown) to clarify the specific
mechanism associated with our findings. Our study will
further demonstrate certain miRNAs and lncRNAs
could be pre-metastatic biomarkers, prognostic tools
and potential therapeutic targets.
Conclusions
Our mouse model with the surgical removal of the
tumor-bearing lymph node greatly simulated the inci-
dence of tumor metastasis after surgery in clinical prac-
tice [4, 21] and allowed us to observe metastatic niche
changes in distant organs. Our study indicates that sur-
gical removal of the tumor-bearing lymph node pro-
moted tumor metastasis to lung and liver; higher
expression level of LOX and a larger number of CD11b+
cells in lung and liver facilitated the recruitment and
colonization of disseminated tumor cells; higher CD169+
and CD11c+ cells number in PALN in groups without
surgical removal of SILN might reduce the tumor metas-
tasis to lung and liver.
A greater understanding of the formation of the meta-
static niche will help our investigation into the preven-
tion and treatment of tumor metastasis.
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